Life Sciences Blog
- Blog: Biologics BlogFederal Circuit Affirms Apotex Bench Trial Win in Neulasta Biosimilar SuitPosted on November 21, 2017 by On November 13, The Federal Circuit issued a decision affirming a district court judgment that Apotex did not infringe Amgen’s recombinant protein patent in its abbreviated Biologics License Applications referencing Amgen’s Neulasta and Neupogen. Judge James Cohn of the Southern District of Florida ruled in Apotex’s favor in September 2016 after a bench trial. On [...]
- Blog: Waller Law BlogSEC Chairman Sees ICOs as Securities OfferingsPosted on November 16, 2017 by Marc J. Adesso,Wes ScottSEC Chairman Jay Clayton spoke at the PLI Annual Institute on Securities Regulation in re: The DAO and his skepticism about ICOs being a securities offering.
- Blog: Biotech Business LawyerGenetically Modified Rice vs. ChinaPosted on March 11, 2013 by biotechbusinesslawyerA March 7, 2013 piece on Morning Edition, the morning news program from National Public Radio, raised a lot of questions. “In A Grain Of Golden Rice, A World Of Controversy Over GMO Foods” told the story of golden rice, … Continue reading →